A novel approach to the treatment of early stage Hodgkin's disease with mitoxantrone-based regimen followed by involved field radiotherapy.

被引：0
|
作者：
O'Brien, TM
Anupama, R
Venugopal, P
Kaplan, EH
Gupta-Burt, S
Foster, GS
Gregory, SA
机构：
[1] Rush Canc Inst, Sect Hematol, Chicago, IL USA
[2] Rush Univ, Dept Radiat Oncol, Chicago, IL 60612 USA
[3] Rush Univ, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA
[4] Rush N Shore Med Ctr, Skokie, IL USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4398
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [21] Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease
    Viviani, S
    Bonfante, V
    Santoro, A
    Zanini, M
    Devizzi, L
    Di Russo, A
    Soncini, F
    Villani, F
    Ragni, G
    Valagussa, P
    Bonadonna, G
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (05): : 275 - 282
  • [22] COMBINED-MODALITY THERAPY WITH MOPP MITOXANTRONE-BV+ INVOLVED FIELD RADIOTHERAPY FOR EARLY CLINICAL STAGE HODGKINS-DISEASE
    SMITH, MR
    COMPEAN, R
    VARTERASIAN, M
    LATTIN, P
    EILENDER, D
    HARMS, P
    ALKATIB, AM
    BLOOD, 1994, 84 (10) : A161 - A161
  • [23] Combined VBM chemotherapy and involved field (IF) radiotherapy in early stage Hodgkin's lymphoma (HL): A single centre experience
    Cocorocchio, Emilia
    Peccatori, Fedro A.
    Gigli, Federica
    Bassi, Simona
    Nassi, Luca
    Calabrese, Liliana
    Travaini, Laura
    Piperno, Gaia
    Preda, Lorenzo
    Pruneri, Giancarlo
    Liptrott, Sarah J.
    Alietti, Alessandra
    Martinelli, Giovanni
    BLOOD, 2007, 110 (11) : 186B - 186B
  • [24] Analysis of efficacy and long-term toxicity in the treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by limited radiotherapy
    Balo, A
    De Vecchi, P
    Franchini, P
    Brusamolino, E
    Lunghi, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S332 - S332
  • [25] Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radiotherapy:: analysis of efficacy and long-term toxicity
    Brusamolino, E
    Lunghi, F
    Orlandi, E
    Astori, C
    Passamonti, F
    Baraté, C
    Pagnucco, G
    Baio, A
    Franchini, P
    Lazzarino, M
    Bernasconi, C
    HAEMATOLOGICA, 2000, 85 (10) : 1032 - 1039
  • [26] Tailored-treatment for early stage Hodgkin's disease
    Epelbaum, R
    Ben-Shahar, M
    Avital, D
    Menashe, N
    Rosenbaum, C
    Faraggi, D
    Dahan, G
    Ben-Arie, Y
    Kuten, A
    Haim, N
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S334 - S334
  • [27] Late effects of treatment for early stage Hodgkin's disease
    Brierley, JD
    Rathmell, AJ
    Gospodarowicz, MK
    Sutcliffe, SB
    Munro, A
    Tsang, R
    Pintilie, M
    BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1300 - 1310
  • [28] Current treatment strategies in early stage hodgkin’s disease
    Josting A.
    Diehl V.
    Current Treatment Options in Oncology, 2003, 4 (4) : 297 - 305
  • [29] Early stage infradiaphragmatic Hodgkin's disease:: results of radiotherapy and review of the literature
    Córdoba, S
    Romero, J
    De la Torre, A
    Valcárcel, F
    Magallón, R
    Regueiro, CA
    García-Berrocal, MI
    RADIOTHERAPY AND ONCOLOGY, 2003, 67 (03) : 259 - 263
  • [30] ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results
    Bonadonna, G
    Bonfante, V
    Viviani, S
    Di Russo, A
    Villani, F
    Valagussa, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2835 - 2841
12345